SILO Silo Pharma, Inc.
Price Chart
Executive Summary
Silo Pharma filed a Certificate of Change effecting a 1-for-15 reverse stock split, effective June 2, 2026, to regain compliance with Nasdaq listing requirements. The authorized common shares were reduced proportionately from 100M to ~6.67M, and the split was automatically incorporated into the company's active registration statements.
Actionable Insight
The reverse split is a mechanical recapitalization to meet Nasdaq's minimum bid price requirement. Monitor the next 10-Q for the post-split share count and cash position. The inclusion of active shelf/S-1 registration statements suggests potential future equity issuance is still available, which could create overhang.
Key Facts
- Filed on June 1, 2026, effective June 2, 2026 at 4:01 p.m. ET; began trading on split-adjusted basis June 3, 2026.
- 1-for-15 reverse stock split of common stock, par value $0.0001 per share.
- Authorized common shares reduced from 100,000,000 to 6,666,667.
- CUSIP changed to 82711P 300; trading symbol SILO unchanged.
- No fractional shares issued; fractional holdings were rounded up to the next whole share.
- Proportionate adjustments made to outstanding stock options, warrants, and shares reserved under equity plans.
- The company has active S-1 (Nos. 333-280855, 333-291129) and S-3 (No. 333-276658) registration statements; the reverse split was incorporated by reference to adjust share amounts under Rule 416(b).
Financial Impact
No immediate financial impact; mechanical capital structure adjustment. Reduces share count and authorized shares by 93%.
Risk Factors
- Post-split share price may not sustain above $1.00, risking delisting.
- Registered shares under S-1 and S-3 could lead to dilutive offerings.
- Low market cap ($6M) makes the stock volatile post-split.
- Historical prior neutral calls on SILO averaged 40% win rate T+20, suggesting market may not react predictably.
Market Snapshot
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-064804 |
| Document: ea029311101ex3-1.htm | 0001213900-26-064804 |
| Document: 0001213900-26-064804-index-headers.html | 0001213900-26-064804 |
| Document: 0001213900-26-064804-index.html | 0001213900-26-064804 |
| Document: 0001213900-26-064804.txt | 0001213900-26-064804 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 3, 2026
9d ago
|
8-K
| $6.11 $5.90 | ▼ −3.44% | ▼ −0.84% | $6.63 (+8.51%) |
|
Jun 1, 2026
11d ago
|
8-K
| $4.99 $5.25 | ▲ +5.26% | ▲ +5.12% | $6.63 (+32.89%) |
|
Apr 29, 2026
6w ago
|
Press Release
| $0.4490 $0.4420 | ▼ −1.56% | ▼ −2.58% | $6.63 (+1376.61%) |
|
Apr 22, 2026
7w ago
|
Press Release
| $0.4740 $0.5000 | ▲ +5.49% | ▲ +4.70% | $6.63 (+1298.73%) |
|
Apr 16, 2026
8w ago
|
EFFECT
| $0.5090 $0.5150 | ▼ −1.18% | ▲ +0.04% | $6.63 (−1202.55%) |
|
Apr 14, 2026
8w ago
|
EFFECT
| $0.4000 $0.4100 | ▲ +2.50% | ▲ +1.73% | $6.63 (+1557.50%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access